Shree Rajasthan Syntex reports Q2 FY27 unaudited results

Shree Rajasthan Syntex Ltd. has announced the outcome of its Board Meeting held on November 5, 2026. The board considered and approved the unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The company also provided details on the utilization of funds raised through a preferential issue, confirming that all funds raised have been fully utilized as per the stated objects and no deviation was noted.

Board Approves Financial Results

Shree Rajasthan Syntex Ltd. informed the stock exchanges on November 5, 2026, about the outcome of its Board of Directors’ meeting. The meeting, which commenced at 12:30 PM and concluded at 05:00 PM on August 5, 2026, saw the board consider and approve the company’s unaudited standalone financial results for the quarter and half-year ended September 30, 2026. This approval was made in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Trading Window Closure

Further to the financial results announcement, the company noted that the trading window for its securities has been closed effective October 1, 2026. This closure will remain in effect until 48 hours after the declaration of the financial results, adhering to relevant SEBI circulars and the Prohibition of Insider Trading (Amendment) Regulations, 2018.

Fund Utilization Details

In a separate disclosure, Shree Rajasthan Syntex Ltd. provided a detailed statement on the utilization of funds amounting to Rs. 10,76,56,250 raised through a preferential issue. The funds were raised at Rs. 13.25 per share via the issuance of 8,125,000 equity shares on November 28, 2025. The accompanying certificate from the auditors, Doogar & Associates, confirms that as of September 30, 2026, all allocated funds have been utilized. The total funds utilized up to September 30, 2026, were Rs. 1009.17 lakhs for repayment of financial creditors, Rs. 65.00 lakhs for employee dues, Rs. 456.56 lakhs for working capital requirements, and Rs. 259.30 lakhs for capital expenditure. A total of Rs. 40.70 lakhs was utilized during the period from April 1, 2026, to September 30, 2026. The company reported no deviation or variation in the utilization of these funds, with no unutilized amount remaining.

Source: BSE

Previous Article

India Shelter Finance reports investor presentation for Q2FY27

Next Article

Molbio Diagnostics reports unaudited financial results for Q2 FY27